As we found BME in mature TAM TKO mice, and this is a phenomenon present in preclinical RA, it is interesting to investigate whether it would be effective to treat these patients with GAS6 in a preclinical stage to stop the progression of BME and subsequent bone erosions. This evidence concerns the gene GAS6 and rheumatoid arthritis.